Bioaide Technologies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.95 M
as on 16-11-2024
- Company Age 28 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.00 Cr
as on 16-11-2024
- Satisfied Charges ₹ 6.00 Cr
as on 16-11-2024
- Revenue 34.40%
(FY 2023)
- Profit 31.41%
(FY 2023)
- Ebitda 40.45%
(FY 2023)
- Net Worth 15.78%
(FY 2023)
- Total Assets 18.45%
(FY 2023)
About Bioaide Technologies
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.95 M.
The company currently has active open charges totaling ₹8.00 Cr. The company has closed loans amounting to ₹6.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pawan Kapur, Roopam Kapur, and Vijay Goel serve as directors at the Company.
- CIN/LLPIN
U51397DL1996PTC081135
- Company No.
081135
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Aug 1996
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Bioaide Technologies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pawan Kapur  | Director | 01-Feb-2000 | Current |
| Roopam Kapur | Director | 17-Aug-2009 | Current |
| Vijay Goel | Director | 17-Jul-2021 | Current |
Financial Performance of Bioaide Technologies.
Bioaide Technologies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 34.4% increase. The company also saw a substantial improvement in profitability, with a 31.41% increase in profit. The company's net worth Soared by an impressive increase of 15.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bioaide Technologies?
In 2023, Bioaide Technologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 03 Nov 2016 | ₹8.00 Cr | Open |
Others Creation Date: 16 Feb 2016 | ₹2.90 Cr | Satisfied |
Bank Of India Creation Date: 24 Nov 2010 | ₹1.80 Cr | Satisfied |
How Many Employees Work at Bioaide Technologies?
Unlock and access historical data on people associated with Bioaide Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bioaide Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bioaide Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
